|

Comparator Clinical Trials

2 actively recruiting trials across 1 location

Pipeline

Phase 3: 1

Top Sponsors

  • Daewon Pharmaceutical Co., Ltd.1
  • AbbVie1

Indications

  • Plaque Psoriasis, Psoriatic Arthritis, Crohn's Disease, or Other Conditions for Which Risankizumab is an FDA-approved Treatment1
  • Perennial Allergic Rhinitis Accompanied by Asthma1
  • Arthritis1
  • Asthma1

Other1 trial

Study to Evaluate the Efficacy and Safety of DW1807 in Perennial Allergic Rhinitis Patients With Asthma
Phase 3

Morrisville, North Carolina1 trial

Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications

Evidera, a PPD Business Unit /ID# 238688

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.